Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSE Regulatory News (SSE)

Share Price Information for SSE (SSE)

Share Price is delayed by 15 minutes
Get Live Data
2,327.00    -20.00 (-0.85%)
Bid:
2,326.00
Ask:
2,327.00
Spread: 1.00 (0.043%)
Market Cap: £28.07b
SSE Live PriceLast checked at - London Stock Exchange

Intraday SSE Share Chart

Board Appointments

24 Jun 2021 16:03

RNS Number : 0576D
SSE PLC
24 June 2021
 

 

SSE PLC

BOARD APPOINTMENTS

The Board of SSE plc is pleased to announce the appointment of two new non-Executive Directors, The Rt Hon Elish Angiolini QC and Debbie Crosbie, both of whom will join the Board and Nomination Committee on 1 September 2021. The appointments are the result of a comprehensive search and selection process. Following these appointments, the Board of SSE plc will comprise the Chair, three Executive Directors and eight non-Executive Directors; and will comprise six men and six women.

The Rt Hon Elish Angiolini QC

Elish has been Principal of St Hugh's College, Oxford since 2012 and is also a Pro-Vice Chancellor of Oxford University and Chancellor of the University of the West of Scotland. Prior to her career in academia, Elish had an extensive public sector legal career, serving as Lord Advocate of Scotland from 2006 to 2011 - across two government administrations - having previously been Solicitor General for Scotland. Since then she has also carried out a number of independent public inquiries and reviews for both the UK and Scottish Governments.

 

Elish is Chair of the Disciplinary Board of the Institute of Chartered Accountants of Scotland (ICAS) and a non-Executive Board member of the Medical and Dental Defence Union of Scotland. She acts as a Patron of several charities and was awarded a Damehood in 2011 for her legal achievements.

 

Debbie Crosbie

Debbie is currently Chief Executive Officer of TSB and has over 25 years of experience in Scottish financial services. Prior to her appointment at TSB in 2019 she was an Executive Director and Chief Operating Officer of Clydesdale Bank, having worked for 22 years at National Australia Bank Group Europe.

 

Debbie is a fellow of the Chartered Institute of Bankers and a member of the Glasgow Economic Leadership Board and the Strathclyde University Business School Advisory Board.

Each Director of SSE plc is subject to annual re-appointment and these new appointments to the Board from September 2021 will be the subject of separate resolutions at the Company's Annual General Meeting 2022.

Sir John Manzoni, Chair of SSE plc, said:

"I am very pleased that Elish and Debbie are joining SSE's Board.  Elish has exceptional legal and academic experience and Debbie has a wealth of financial knowledge so both will bring deep insights from their extensive careers. Both will bring a Scottish and wider perspective and will add further depth to the Board. I look forward to working with them, the rest of the Board and the wider SSE team as we continue to take SSE forward, in doing so, helping the UK and other countries deliver on net zero ambitions".

The Company confirms there is no further information required to be disclosed pursuant to paragraph 9.6.13 of the UK Listing Rules.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEZLFLFQLBBBF
Date   Source Headline
10th Oct 20244:10 pmRNSDirector/PDMR Shareholding
10th Oct 20247:00 amRNSTransaction in Own Shares
9th Oct 20249:03 amRNSDirector/PDMR Shareholding
9th Oct 20247:00 amRNSTransaction in Own Shares
8th Oct 20247:00 amRNSTransaction in Own Shares
7th Oct 20247:00 amRNSTransaction in Own Shares
4th Oct 20247:00 amRNSTransaction in Own Shares
3rd Oct 20247:00 amRNSTransaction in Own Shares
3rd Oct 20247:00 amRNSNotification of Closed Period
2nd Oct 202410:47 amRNSDirector/PDMR Shareholding
2nd Oct 20247:00 amRNSTransaction in Own Shares
1st Oct 20243:46 pmRNSTotal Voting Rights
1st Oct 20247:00 amRNSTransaction in Own Shares
30th Sep 202410:03 amRNSNon-Discretionary Share Buyback Programme
25th Sep 20244:38 pmRNSDirector/PDMR Shareholding
23rd Sep 20243:30 pmRNSDirector/PDMR Shareholding
17th Sep 20248:00 amRNSAdditional Listing
10th Sep 20244:44 pmRNSDirector/PDMR Shareholding
3rd Sep 20248:25 amRNSUK Contracts for Difference Allocation Round 6
2nd Sep 20247:00 amRNSTotal Voting Rights
30th Aug 202410:00 amRNSBlock Listing Six Monthly Return
30th Aug 20248:30 amRNSDirector/PDMR Shareholding
29th Aug 202412:00 pmRNSScrip Alternative
28th Aug 20245:12 pmRNSIssuance of Green Bond
9th Aug 202410:57 amRNSDirector/PDMR Shareholding
1st Aug 202411:32 amRNSScrip Dividend Scheme
1st Aug 20247:00 amRNSTotal Voting Rights
30th Jul 20243:41 pmRNSHolding(s) in Company
22nd Jul 20249:06 amRNSHolding(s) in Company
18th Jul 20244:16 pmRNSResult of AGM
18th Jul 20247:31 amRNSOfgem RIIO-3 Sector Specific Methodology Decision
18th Jul 20247:00 amRNSQ1 Trading Statement
10th Jul 20243:36 pmRNSDirector/PDMR Shareholding
10th Jul 20249:28 amRNSDirector/PDMR Shareholding
9th Jul 20243:26 pmRNSDirector/PDMR Shareholding
9th Jul 20247:00 amRNSSSE & partners advance 2GW offshore windfarm in NL
1st Jul 20249:25 amRNSTotal Voting Rights
14th Jun 20241:00 pmRNSAnnual Financial Report
14th Jun 202411:22 amRNSDirector/PDMR Shareholding
10th Jun 20243:40 pmRNSDirector/PDMR Shareholding
3rd Jun 20244:15 pmRNSDirector/PDMR Shareholding
3rd Jun 20247:00 amRNSTotal Voting Rights
23rd May 20249:23 amRNSDividend Timetable
23rd May 20247:01 amRNSDirector Declaration
22nd May 20247:00 amRNSPreliminary Results for the year ended 31 March 24
8th May 202412:05 pmRNSDirector/PDMR Shareholding
1st May 20247:00 amRNSTotal Voting Rights
10th Apr 20244:22 pmRNSDirector/PDMR Shareholding
9th Apr 20242:31 pmRNSDirector/PDMR Shareholding
2nd Apr 20249:37 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.